Fagoterapia will be part of IPCEI “Med4Cure”, the first important project of European interest in the health value chain.
2024-06-03After a long selection process, national and by the European Commission 🇪🇺, we are proud that fagoterapia lab results among the five Italian companies 🇮🇹 together with Takis, Holostem, Sanofi, and Nurex to take part to the Med4cure project and to access funding from the IPCEI health fund, Important Projects of Common European Interest.🚀
Thanks to such State aid we will be able to develop our Phages4All project to bring bacteriophage therapy to patients with antibiotic-resistant and/or difficult-to-treat bacterial infections.
Our project involves four direct partners from IPCEI, two associate partners and more than 20 indirect partners from national and European companies, hospitals and research centers.
For more information, please visit the MIMIT website.